ICICI Direct's research report on SBI Life Insurance
Premium growth continued to remain robust at 33% YoY to Rs 28700 crore in 9MFY20, led by robust traction of 35% YoY in new business premium (NBP) and steady renewals at Rs 15910 crore; up 31% YoY. Within NBP, traction in individual business remained healthy at ~26% YoY in 9MFY20 to Rs 8040 crore. Protection business (individual + group) witnessed robust traction of 37% YoY to Rs 1440 crore in 9MFY20. Total protection NBP as a proportion of total NBP continued to remain steady at 11% in 9MFY20.
Outlook
Operating RoEV is seen improving at ~18.5% in FY22E. On rollover to FY22E, we revise our target price to Rs 1180 (vs. earlier Rs 1000), valuing the stock at 3.2x FY22E EV. We remain positive on SBI Life structurally being a play on growth led by distribution, brand reach and adequate product mix. We maintain BUY.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!